Analysts Are Bullish on These Healthcare Stocks: GTHX, OFIX


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on G1 Therapeutics Inc (NASDAQ: GTHX) and Orthofix (NASDAQ: OFIX) with bullish sentiments.

G1 Therapeutics Inc (NASDAQ: GTHX)

BTIG analyst Dane Leone maintained a Buy rating on G1 Therapeutics Inc yesterday and set a price target of $60. The company’s shares closed yesterday at $47.86, close to its 52-week high of $52.76.

According to TipRanks.com, Leone is a 5-star analyst with an average return of 20.2% and a 67.9% success rate. Leone covers the Healthcare sector, focusing on stocks such as Voyager Therapeutics Inc, Vertex Pharmaceuticals, and Blueprint Medicines.

Currently, the analyst consensus on G1 Therapeutics Inc is a Strong Buy with an average price target of $60.33.

See today’s analyst top recommended stocks >>

Orthofix (NASDAQ: OFIX)

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Orthofix, with a price target of $62. The company’s shares closed yesterday at $57.67.

Zimmerman commented:

“$62 PT OFIX announced after the close today that they will be realigning business units into two segments, Extremities while still reporting all four business segments on a quarterly basis. We view the realignment as an incremental positive as it should allow OFIX to drive sales synergies through a more streamlined sales structure. Specifically, the realignment should provide OFIX with an increased ability to pull through complementary spine products and deepen customer relationships. We caught up with mgmt. post close and the realignment is not specifically a cost-cutting measure (although there could be some cost savings in future years).”

According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of 27.2% and a 62.5% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Integra Lifesciences, OrthoPediatrics Corp, and SeaSpine Holdings.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Orthofix with a $62 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts